Showing results (141-150 of 293) with videos related to
Sort By:
Pageof 30
Suicide & Life-Threatening Behavior|March 25, 2022
Awareness isn't saving lives: An experimental exploration of suicide risk reduction methods for emerging adultsTravis J Pashak, Carly S Percy, Emma J Trierweiler, et al.Cancer|February 26, 2020
Evaluation of toxicities related to novel therapy in clinical trials for women with gynecologic cancerYeh Chen Lee, Lisa Wang, Elise C Kohn, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2017
Challenges and Opportunities in Adapting Clinical Trial Design for ImmunotherapiesLillian L Siu, S Percy Ivy, Erica L Dixon, et al.The Journal of Rheumatology. Supplement|July 1, 1982
Gold therapy in rheumatoid arthritis. Interim report of the Canadian multicenter prospective trial comparing sodium aurothiomalate and auranofinH A Menard, F Beaudet, P Davis, et al.Journal of Cellular Physiology|July 11, 2006
Regulation of protein phosphatase 1gamma activity in hypoxia through increased interaction with NIPP1: implications for cellular metabolismKathrina M Comerford, Martin O Leonard, Eoin P Cummins, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2017
From Famine to Feast: Developing Early-Phase Combination Immunotherapy Trials WiselyDaphne Day, Arta M Monjazeb, Elad Sharon, et al.Nature Reviews. Clinical Oncology|April 9, 2015
Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical updateNaoko Takebe, Lucio Miele, Pamela Jo Harris, et al.Gastroenterology|January 2, 2008
The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitisEoin P Cummins, Fergal Seeballuck, Stephen J Keely, et al.Antioxidants & Redox Signaling|May 9, 2009
Hypoxia activates NF-kappaB-dependent gene expression through the canonical signaling pathwayKathryn M Oliver, John F Garvey, Chin Teck Ng, et al.Journal of the National Cancer Institute|September 1, 2022
Implementing Modernized Eligibility Criteria in US National Cancer Institute Clinical TrialsAndrea M Denicoff, S Percy Ivy, Tami T Tamashiro, et al.Pageof 30